Objetivo
Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.
Ámbito científico
Convocatoria de propuestas
Data not availableRégimen de financiación
RGI - Research grants (individual fellowships)Coordinador
54006 THESSALONKI
Grecia